Inorganic mercury pharmacokinetics in man: a hybrid model
A four-compartment model is presented that simulates inorganic mercury [Hg(II)] pharmacokinetics in blood, tissue, and excreta over a 70-day period. Simulations are validated against data collected from five human subjects, and previously analyzed.In the model, two compartments simulate Hg(II) in bl...
Saved in:
Published in | Xenobiotica Vol. 55; no. 1; p. 4 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
England
2025
|
Subjects | |
Online Access | Get more information |
Cover
Loading…
Abstract | A four-compartment model is presented that simulates inorganic mercury [Hg(II)] pharmacokinetics in blood, tissue, and excreta over a 70-day period. Simulations are validated against data collected from five human subjects, and previously analyzed.In the model, two compartments simulate Hg(II) in blood: one for mobile-Hg(II) and the other for immobile-Hg(II). Two corresponding compartments simulate Hg(II) in tissue. Mobile-Hg(II) represents Hg(II) available for transport across cell membranes. Immobile-Hg(II) represents Hg(II) that is not easily transported.Following dosing, blood total-Hg(II) droped rapidly in all subjects. Blood mobile-Hg(II) also droped rapidly with a concomitant rise in blood immobile-Hg(II). For four subjects, immobile-Hg(II) became the dominant Hg(II) species in blood by day 4. For subject five, mobile-Hg(II) remained dominant in blood for the study duration.Tissue mobile-Hg(II) declined rapidly for four of the subjects, with a simultaneous rapid rise in tissue immobile-Hg(II). In subject 5, tissue mobile-Hg(II) declined linearly, and immobile-Hg(II) accumulated slowly in tissue. For all subjects, tissue mobile-Hg(II) is the primary source of fecal Hg(II). The major source for Hg(II) excreted into the urine is immobile-Hg(II) from tissue. |
---|---|
AbstractList | A four-compartment model is presented that simulates inorganic mercury [Hg(II)] pharmacokinetics in blood, tissue, and excreta over a 70-day period. Simulations are validated against data collected from five human subjects, and previously analyzed.In the model, two compartments simulate Hg(II) in blood: one for mobile-Hg(II) and the other for immobile-Hg(II). Two corresponding compartments simulate Hg(II) in tissue. Mobile-Hg(II) represents Hg(II) available for transport across cell membranes. Immobile-Hg(II) represents Hg(II) that is not easily transported.Following dosing, blood total-Hg(II) droped rapidly in all subjects. Blood mobile-Hg(II) also droped rapidly with a concomitant rise in blood immobile-Hg(II). For four subjects, immobile-Hg(II) became the dominant Hg(II) species in blood by day 4. For subject five, mobile-Hg(II) remained dominant in blood for the study duration.Tissue mobile-Hg(II) declined rapidly for four of the subjects, with a simultaneous rapid rise in tissue immobile-Hg(II). In subject 5, tissue mobile-Hg(II) declined linearly, and immobile-Hg(II) accumulated slowly in tissue. For all subjects, tissue mobile-Hg(II) is the primary source of fecal Hg(II). The major source for Hg(II) excreted into the urine is immobile-Hg(II) from tissue. |
Author | Su, Joe Awaness, Ayda Farris, Fred |
Author_xml | – sequence: 1 givenname: Fred surname: Farris fullname: Farris, Fred organization: Department of Pharmaceutical Sciences, School of Pharmacy, Westcoast University, Los Angeles, CA, USA – sequence: 2 givenname: Ayda surname: Awaness fullname: Awaness, Ayda organization: Department of Pharmaceutical Sciences, School of Pharmacy, Westcoast University, Los Angeles, CA, USA – sequence: 3 givenname: Joe surname: Su fullname: Su, Joe organization: Department of Pharmaceutical Sciences, School of Pharmacy, Westcoast University, Los Angeles, CA, USA |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/39792020$$D View this record in MEDLINE/PubMed |
BookMark | eNo1j8tKAzEYhYMo9qKPoOQFpv65TC7upFgtFNzouuRqo01myLSLeXsH1M05i_Nx4Fugy9KVgNAdgRUBBQ8AXCva8hUFOgXnSkt9geaECdG0mqoZWgzDFwAIQuk1mrFpn1iYI70tXf00JTmcQ3XnOuL-YGo2rvtOJZySG3AqOJvyiA0-jLYmj3Pnw_EGXUVzHMLtXy_Rx-b5ff3a7N5etuunXeNoK08NI5qryLxWjFppORXRqig8UdIL03oRqI4kBm4dsxAoRC8kY4REbkBOWkt0__vbn20Oft_XlE0d9_8O9AewjUj6 |
ContentType | Journal Article |
DBID | CGR CUY CVF ECM EIF NPM |
DOI | 10.1080/00498254.2024.2448979 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | no_fulltext_linktorsrc |
Discipline | Chemistry Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1366-5928 |
ExternalDocumentID | 39792020 |
Genre | Journal Article |
GroupedDBID | --- .GJ 00X 03L 0R~ 123 29R 36B 4.4 53G 5RE 5VS AACCU AALIY AALUX AAMIU AAPUL AAPXX AAQRR ABBKH ABCRQ ABDBF ABEIZ ABJNI ABLIJ ABLKL ABUPF ABWVI ABXYU ACENM ACGEJ ACGFS ACIEZ ACKYO ACUHS ADCVX ADRBQ ADXPE ADYSH AECIN AEGXH AENEX AEOZL AFAUU AFKVX AFQCT AFRVT AGAFX AGDLA AGFJD AGRBW AGYJP AIJEM AIRBT AJEBJ AJWEG AJXHO AKBVH ALMA_UNASSIGNED_HOLDINGS ALQZU ALYBC AMPGV AOYHP AWYRJ BABNJ BLEHA BOHLJ BVLLS CAG CCCUG CGR COF CS3 CUY CVF DEIEU DKSSO DLVIE DTRLO DU5 DZHFC EAP EBC EBD EBS EBX ECM EDH EIF EJD EMB EMK EMOBN EPL ESX F5P H13 HZ~ JFOCU KRBQP KWAYT KYCEM L7B LJTGL M44 M4Z MK0 NPM NUSFT O9- OVD QRXOQ RNANH RVRKI SV3 TBQAZ TEORI TERGH TFDNU TFL TFW TUROJ TUS UHWXJ V1S ZGI ZXP ~1N ~KM |
ID | FETCH-LOGICAL-c257t-31948f3d9832b7b426fb8f6d187d6a5d6e29f1fe4bc3b0e20fd673311f4a07982 |
IngestDate | Fri May 02 01:40:58 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | pharmacokinetics, hybrid model multicompartment model Mercury mercury transport inorganic mercury |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c257t-31948f3d9832b7b426fb8f6d187d6a5d6e29f1fe4bc3b0e20fd673311f4a07982 |
PMID | 39792020 |
ParticipantIDs | pubmed_primary_39792020 |
PublicationCentury | 2000 |
PublicationDate | 2025-00-00 |
PublicationDateYYYYMMDD | 2025-01-01 |
PublicationDate_xml | – year: 2025 text: 2025-00-00 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | Xenobiotica |
PublicationTitleAlternate | Xenobiotica |
PublicationYear | 2025 |
SSID | ssj0006122 |
Score | 2.4087274 |
Snippet | A four-compartment model is presented that simulates inorganic mercury [Hg(II)] pharmacokinetics in blood, tissue, and excreta over a 70-day period.... |
SourceID | pubmed |
SourceType | Index Database |
StartPage | 4 |
SubjectTerms | Adult Humans Male Mercury - blood Mercury - pharmacokinetics Mercury - urine Models, Biological Tissue Distribution |
Title | Inorganic mercury pharmacokinetics in man: a hybrid model |
URI | https://www.ncbi.nlm.nih.gov/pubmed/39792020 |
Volume | 55 |
hasFullText | |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bS8MwFA5OQfciOu838iB72Sq9pJf4JsMxBWXgBnsbzQ2HrA6dSP31njTtVsfEy0soTSkl38nJOWm-7yB07jDiRCLmlssjzyKEwJxzqWMJG_Ihm0HAEWpy8t190OmT24E_KKrZ5-ySKbvgH0t5Jf9BFe4Brpol-wdkZy-FG3AN-EILCEP7K4xvElOUiTfG8oXD6DQmuRL1EwSPmQDzKNEHVA2l-THV9CxT_KYclA5kosWYpqVjO1qb0agPtItantoq3mPtGTN_ks5T-Yc3sw8vy1sIrl_aQpDG7XlBYPk0p2nnftHI537B3zg5stT1FmcVCdVJJ2TeLjSQ_FFTLKYEx2Sc4aH_KMJT9s-9C4rYRVcFVSA30MVO9Q5NvvpCxOYWTC2tob7se6povXjHQjaRRRW9LbSZpwP4ymC7jVZkUkMbraIKXw3VuwbRtIl7c6rcaxPXcXeuOp7uIDozBpwbA140BjxKMBjDJY6xMQWcmcIu6reve62OldfFsDg42Cksm5REyhMUvDELGcRYikUqEE4UiiD2RSBdqhwlCeMes6VrKxHo0pyOIrEdwnDsodXkOZEHCNuCiwhCTO4STvyQMKkUgVkbxRRCecUO0b4ZnuHEiJ8Mi4E7-rbnGFXnRnaC1hTMNnkKoduUnWVYfQKk_z4_ |
linkProvider | National Library of Medicine |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Inorganic+mercury+pharmacokinetics+in+man%3A+a+hybrid+model&rft.jtitle=Xenobiotica&rft.au=Farris%2C+Fred&rft.au=Awaness%2C+Ayda&rft.au=Su%2C+Joe&rft.date=2025-01-01&rft.eissn=1366-5928&rft.volume=55&rft.issue=1&rft.spage=4&rft_id=info:doi/10.1080%2F00498254.2024.2448979&rft_id=info%3Apmid%2F39792020&rft_id=info%3Apmid%2F39792020&rft.externalDocID=39792020 |